HomeJAGSNPHARM • NSE
add
Jagsonpal Pharmaceuticals Ltd
Previous close
₹330.90
Day range
₹330.30 - ₹340.00
Year range
₹273.60 - ₹514.85
Market cap
8.99B INR
Avg Volume
27.90K
P/E ratio
40.18
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 434.86M | -21.58% |
Operating expense | 235.56M | -8.73% |
Net income | 35.49M | -36.65% |
Net profit margin | 8.16 | -19.21% |
Earnings per share | — | — |
EBITDA | 26.82M | -55.99% |
Effective tax rate | 21.76% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.48B | 29.06% |
Total assets | 2.17B | 11.35% |
Total liabilities | 296.76M | -17.69% |
Total equity | 1.87B | — |
Shares outstanding | 27.09M | — |
Price to book | 4.78 | — |
Return on assets | — | — |
Return on capital | 3.02% | — |
Cash Flow
Net change in cash
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 35.49M | -36.65% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1978
Website
Employees
940